159 related articles for article (PubMed ID: 19744266)
1. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
Francalanci P; Santorelli FM; Saccani S; Bonetti MF; Medicina D; Coni P; Faa G; Callea F
Liver Int; 2009 Nov; 29(10):1593-6. PubMed ID: 19744266
[TBL] [Abstract][Full Text] [Related]
2. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
[TBL] [Abstract][Full Text] [Related]
3. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
[TBL] [Abstract][Full Text] [Related]
4. [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?].
Manekeller S; Sauerbruch T; Fischer HP; Propping P; Hirner A
Z Gastroenterol; 2010 Oct; 48(10):1211-4. PubMed ID: 20886426
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human.
Giovannoni I; Callea F; Stefanelli M; Mariani R; Santorelli FM; Francalanci P
Liver Int; 2015 Jan; 35(1):198-206. PubMed ID: 24529185
[TBL] [Abstract][Full Text] [Related]
6. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
7. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
Rubel LR; Ishak KG; Benjamin SB; Knuff TE
Arch Pathol Lab Med; 1982 Dec; 106(13):678-81. PubMed ID: 6291490
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and genetic characterization of the M Cagliari alpha-1-antitrypsin molecule (M-like alpha-1-antitrypsin deficiency).
Sergi C; Consalez GG; Fabbretti G; Brisigotti M; Faa G; Costa V; Romeo G; Callea F
Lab Invest; 1994 Jan; 70(1):130-3. PubMed ID: 8302013
[TBL] [Abstract][Full Text] [Related]
9. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha1-antitrypsin.
Janciauskiene S; Eriksson S; Callea F; Mallya M; Zhou A; Seyama K; Hata S; Lomas DA
Hepatology; 2004 Nov; 40(5):1203-10. PubMed ID: 15486938
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
Perlmutter DH
Pediatr Res; 2006 Aug; 60(2):233-8. PubMed ID: 16864711
[TBL] [Abstract][Full Text] [Related]
11. Histological examination for Z-gene alpha 1-antitrypsin deficiency in small cell anaplastic carcinoma of the lung.
Sehested M; Hirsch FR; Hou-Jensen K; Hansen HH
Eur J Respir Dis; 1981; 62(2):107-10. PubMed ID: 6263662
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.
Rudnick DA; Perlmutter DH
Hepatology; 2005 Sep; 42(3):514-21. PubMed ID: 16044402
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1-antitrypsin-positive "signet-ring" bile duct adenoma in a patient with M(MALTON) mutation.
Gambarotti M; Medicina D; Baronchelli C; Bercich L; Bonetti F; Facchetti F
Int J Surg Pathol; 2008 Apr; 16(2):218-21. PubMed ID: 18417685
[TBL] [Abstract][Full Text] [Related]
14. [Liver changes suggesting alpha-1-antitrypsin deficiency (a neglected disease)].
Bartók I; Korányi G; Bartók K; Nádor K; Hegedüs C
Orv Hetil; 1989 Sep; 130(36):1911-6, 1919. PubMed ID: 2674844
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
[TBL] [Abstract][Full Text] [Related]
16. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency.
Callea F; Giovannoni I; Francalanci P; Boldrini R; Faa G; Medicina D; Nobili V; Desmet VJ; Ishak K; Seyama K; Bellacchio E
Orphanet J Rare Dis; 2018 May; 13(1):79. PubMed ID: 29769092
[TBL] [Abstract][Full Text] [Related]
17. Isoelectric focusing phenotyping and denaturing gradient gel electrophoresis genotyping: a comparison of two methods in detection of alpha-1-antitrypsin variants.
Ljujic M; Topic A; Divac A; Nikolic A; Petrovic-Stanojevic N; Surlan M; Mitic-Milikic M; Radojkovic D
Transl Res; 2008 May; 151(5):255-9. PubMed ID: 18433707
[TBL] [Abstract][Full Text] [Related]
18. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
[TBL] [Abstract][Full Text] [Related]
19. Alpha-1-antitrypsin deficiency in Southern African hepatocellular carcinoma patients. An immunoperoxidase and histochemical study.
Cohen C; Berson SD; Budgeon LR
Cancer; 1982 Jun; 49(12):2537-40. PubMed ID: 6280844
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
